WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that it received approval from the ...

WALTHAM, Mass., Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ...

Active-Investors.com is currently working on the research report for Apollo Endosurgery, Inc. (NASDAQ: APEN), which also belongs to the Healthcare sector as the Company Corindus Vascular Robotics. Do ...

WALTHAM, Mass., Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...

Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment • “Clinical Review” presented by Ehtisham ...

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ...

Please provide your email address to receive an email when new articles are posted on . The concept of robotic-assisted PCI has been successfully implemented since 2011, allowing for precise ...

GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is ...

Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France Corindus Vascular Robotics, Inc. ("Corindus" or the "Company") (NYSE American: CVRS), a leading developer of ...